Some Essential Facts About Lantheus

Health Care sector company Lantheus posted a -1.18% performance today, while the S&P 500 returned -0.23%.

8 analysts are following Lantheus and have set target prices ranging from $94.0 to $120.0 per share. On average, they have given the company a rating of buy. At today's prices, LNTH is trading -25.75% away from its average analyst target price of $108.38 per share.

Over the last year, LNTH's share price has increased by 42.07%, which represents a difference of 56.19% when compared to the S&P 500. The stock's 52 week high is $87.47 per share whereas its 52 week low is $47.46. With an average free cash flow of $38,295,400.0 that have been growing at an average rate of 27.88% over the last four years, Lantheus is in a position to continue its strong stock performance trend.

Date Reported Cash Flow from Operations (k) Capital Expenditures (k) Free Cash Flow (k) YoY Growth
2022-12-31 $281,781 $260,000 $21,781 -59.6%
2021-12-31 $53,916 $0 $53,916 228.84%
2020-12-31 $16,396 $0 $16,396 -71.89%
2019-12-31 $80,384 $22,061 $58,323 42.04%
2018-12-31 $61,193 $20,132 $41,061 n/a
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.